These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23259345)

  • 1. [Value of biological markers in cardiovascular disease].
    Couderc R; Lefevre G; Fiessinger JN
    Bull Acad Natl Med; 2012 Jan; 196(1):217-22. PubMed ID: 23259345
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple biomarker panels for cardiovascular risk assessment.
    de Lemos JA; Lloyd-Jones DM
    N Engl J Med; 2008 May; 358(20):2172-4. PubMed ID: 18480211
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we focus on novel risk markers and screening tests to better predict and prevent cardiovascular disease? Or are we putting the cart before the horse?
    Wong ND
    Prev Cardiol; 2010; 13(4):149-51. PubMed ID: 20860636
    [No Abstract]   [Full Text] [Related]  

  • 5. Should we focus on novel risk markers and screening tests to better predict and prevent cardiovascular disease? Point.
    Enriquez JR; de Lemos JA
    Prev Cardiol; 2010; 13(4):152-9. PubMed ID: 20860637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does volume status affect BNP and troponin levels as markers of cardiovascular status in peritoneal dialysis?
    Garg R; Singh A; Khaja A; Martin A; Aggarwal K
    Congest Heart Fail; 2009; 15(5):240-4. PubMed ID: 19751426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptide concentrations in centenarians.
    Nybo M; Jeune B; Andersen-Ranberg K
    J Am Geriatr Soc; 2012 May; 60(5):991-3. PubMed ID: 22587866
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute coronary syndrome: the risk of being female.
    Elsaesser A; Hamm CW
    Circulation; 2004 Feb; 109(5):565-7. PubMed ID: 14769676
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma BNP/NT-proBNP assays: what do they target and what else might they recognize?
    Wu AH
    Heart Fail Clin; 2006 Jul; 2(3):291-8. PubMed ID: 17386898
    [No Abstract]   [Full Text] [Related]  

  • 12. N-terminal-pro-B-type natriuretic peptide: universal marker of cardiovascular risk?
    Richards AM; Frampton CM
    Circulation; 2005 Jul; 112(1):9-11. PubMed ID: 15998694
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application.
    Roberts MA; Hedley AJ; Ierino FL
    Nephrology (Carlton); 2011 Mar; 16(3):251-60. PubMed ID: 21342319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing the utility of blood biomarker associations beyond population sample linkage to events in cardiovascular patients.
    Macfadyen RJ; Ng Kam Chuen MJ
    Eur Heart J; 2008 Apr; 29(7):837-9. PubMed ID: 18334472
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated pro-brain natriuretic peptide, troponin T and malnutrition inflammatory score in chronic hemodialysis patients with overt cardiovascular disease.
    Trimarchi H; Muryan A; Campolo-Girard V; Dicugno M; Barucca N; Lombi F; Young P; Pomeranz V; Forrester M; Alonso M; Iriarte R; Díaz ML; Lindholm B
    Nephron Clin Pract; 2011; 117(3):c198-205. PubMed ID: 20805692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-terminal brain natriuretic peptide is related to the presence of diabetic polyneuropathy independently of cardiovascular disease.
    Jurado J; Ybarra J; Ferrandiz M; Comerma L; Pou JM
    Diabetes Care; 2007 Aug; 30(8):e86. PubMed ID: 17855271
    [No Abstract]   [Full Text] [Related]  

  • 18. The reasons of higher NT-proBNP depend on very different conditions.
    Aydogan M; Balta S; Kurt O; Sarlak H; Gumus S; Demirkol S
    Ann Rheum Dis; 2013 Jul; 72(7):e17. PubMed ID: 23632194
    [No Abstract]   [Full Text] [Related]  

  • 19. Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery.
    Nadir MA; Struthers AD
    Heart; 2010 Aug; 96(15):1254; author reply 1254. PubMed ID: 20639243
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding cardiovascular biomarkers.
    Hieronymus L; Wortzman-Show G
    Diabetes Self Manag; 2013; 30(3):16, 18-20. PubMed ID: 23951629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.